Recently, developing computational methods to explore drug-pathway interaction relationships has attracted attention for their potentiality in discovering unknown targets and mechanisms of drug actions. However, mining suitable features of drugs and pathways is challenging for available prediction methods. This paper performed an ensemble learning-based method to predict potential drug-pathway interactions by integrating different drug-based and pathway-based features. The main characteristic of our method lies in using the Relief algorithm for feature selection and regarding three ensemble methods (AdaBoost, Bagging and Random Subspace) for classifiers. Cross validation results showed the AdaBoost algorithm that based on the Decision Tree classifier can obtain a higher prediction accuracy, which indicated the effectiveness of ensemble learning. Moreover, some new predicted interactions were validated by database searching, which demonstrated its potentiality for further biological experiment investigation.
INTRODUCTION
Traditional drug discovery primarily tries to seek the specific drug molecule to act on individual target (Hopkins, 2008) . However, it is well recognized that many drugs are far beyond targeting individual proteins, but rather influencing the complex interactions among the relevant biological pathways. Therefore, the inferences of drug-pathway associations are critical for identifying unknown targeted pathways and drug action mechanisms .
Increasing effort has been devoted to detecting these potential associations and several drugpathway interactions prediction methods have been proposed from different aspects (Subramanian et al., 2005; . Generally, most of the methods attempted to analyze the drug-pathway interactions mainly based on gene expression data. For instance, 'iFad' mainly combined the gene expression and drug sensitivity datasets to analyze the drug-pathway interactions , but it is always difficult to obtain adequate drugpathway information merely on the gene expression data. To tackle the problem, some methods attempt to utilize different machine learning algorithms by integrating more chemical and biological information (Silberberg et al., 2012; Pratanwanich and Lio, 2014; Song et al., 2014) . For instance, protein-protein interaction networks (PPI) (Silberberg et al., 2012) , other target structure information have been utilized effectively recently. However, the extraction and fusion of the drugpathway association information is still challenging for drug-pathway interactions prediction (Song et al., 2014) .
Inspired by the challenges, we attempted to use the ensemble learning methods to predict potential drug-pathway associations. As similar drugs often act similar target proteins, we assume that similar drugs also act on similar pathways. Based on the fact that the drug mode of actions (MoA) is a central concept linking drug structures to a set of biological activities, we used drug structure and MoA similarity to represent drug feature information. Further, we used the 'RNA: AffyHG-U133 (A, B)' gene expression data of NCI-60 cell lines (Reinhold et al., 2012) to obtain related genes which covered by these pathways, then these genes ontology semantic similarity and sequence similarity are calculated to represent pathway information. Further, the drug-pathway network topology information was merged into the drug and pathway feature profiles, respectively.
It is known that ensemble learning methods usually exhibits better generalization performance than a single classifier. In this study, we used three well-established methods: AdaBoost (Freund and Schapire, 1997) , Bagging (Breiman, 1996) and Random SubSpace (Ho, 1998) to achieve a good ensemble result. Meanwhile, three widely used learning methods: Support Vector Machine (SVM) (Cortes and Vapnik, 1995) , Navie Bayesian (NB) (Rish, 2001) and Decision Tree (DT) (Friedl and Brodley, 1997) are chosen as the base classifier. Compared of these method combinations, the AdaBoost algorithm that based on the DT classifier is selected as the final model to predict the drugpathway interactions.
MATERIAL AND METHOD

Dataset
This study focus on 58 pathways that have been proved to be related to cancers (Ahmed et al., 2011) and 362 drugs obtained from KEGG database (Kanehisa et al., 2012) , which contains most of pathways and molecular information in genomics, transcriptomics, proteomics and metabolomics. In addition, these drugs have complete drug information and most of them are proved to be related to these pathways.
Features Construction
(1) Drug features Drug structure-based feature d S : Drug structure similarity is calculated based on their molecular fingerprints which include 881 chemical substructures defined by the PubChem database (Chen et al., 2009) . PaDel-Descriptor (Yap, 2011) was used to convert each drug Mol file into 881 dimensional binary vectors. Then the corresponding fingerprints are used to compute the similarity scores between two drugs by Tanimoto scores (Lipkus, 1999) .
MoA based feature d F : Since drugs which share a similar MoA are likely to target same pathways, thus the drug MoA similarity can be utilized to predict associations between drugs and pathways. Here we retrieved MoA information from DrugBank database (Wishart et al., 2006) and calculate the similarities based on 341 MoAs. We consider drugs as samples and each MoA as a label and take known drug-MoA association matrix M as local correlations. According to the local correlations between labels of samples in drug-MoA interaction network, we calculate the cosine similarity of each two drug vectors in M:
(2)Pathway features This study mainly concentrated on 1863 genes covered by the 58 pathways for the pathway features construction.
Gene ontology Semantic feature p F : The Gene
Ontology terms of 1863 genes were retrieved from Quick GO database (Binns et al., 2009) , and semantic similarity scores between these pathwayrelated genes were calculated by the csbl.go R package (Ovaska et al., 2008) . What's more, the similarity scores between the pathways from gene semantic similarity scores were computed in accordance with the reference (Song et al., 2014) . Gene sequence similarity p S : Sequence similarity between the corresponding pathway-related genes was calculated based on a Smith-Waterman sequence alignment score (Smith et al., 1985) , and the similarity between two pathways can be calculated as the sum of similarity between all the gene sequences related to the two pathways.
(3)Drug-pathway network topology feature The drug-pathway network topology information was calculated based on the literature ( Van et al., 2013) . In the drug-pathway network, the average shortest path of each node and the number of shared drugs or pathways are denoted as , , ,
As showed in 
Features Selection
Existing facts demonstrate that irrelevant and redundant features can lead the model to overfit.
Here we perform the Relief method (Sun et al., 2011) to avoid redundancy of feature variables. At each iteration, the algorithm picks randomly a sample K, then picks at random the feature sample of the instance closest to K from each class, the same class instance is called 'near-hit' and the different class instance is called 'near-miss'. Then the weight vector is updated as:
Thus, the weight of any given feature increases if the distance between K and near-hit is shorter than the distance between K and near-miss for the feature, and decreases otherwise. After n iterations, the relevance vector is updated by dividing each element of the weight vector by n, then feature are selected if their relevance is greater than a threshold k. In this study, we set the threshold as zero and finally selected 551 features with positive weight from 764 features.
Ensemble Learning Method
Ensemble learning is a machine learning paradigm which constructs a set of classifiers and then combines them for classifying data by taking a vote of their predictions (Schwenker, 2013 ). Here we take three well-established methods in practice to achieve a good ensemble. AdaBoost and Bagging are two instance partitioning methods and Random Subspace is a feature partitioning method ( Van et al., 2013) .
AdaBoost
AdaBoost is an iterative algorithm where the conjuncture of many weak classifiers is employed to construct a 'strong' classifier (Ho, 1998) . It works by choosing a base algorithm and iteratively improving it by accounting for the incorrectly classified examples in the training set. The final predictions are retrieved from a weighted vote. The AdaBoost algorithm's pseudo code is shown as followed:
Bagging
Bagging is an ensemble meta-estimator where each base classifier is trained on random subsets of the original dataset and then aggregated their individual predictions to form a final prediction (Breiman, 1996) . It improves the stability and reduces variance, and avoids overfitting of learning algorithms. The base classifiers' combination strategy for Bagging is majority vote. The Bagging algorithm pseudo code is shown as followed:
Random Subspace
Random Subspace is a combination model that consists of several classifiers and each are trained on randomly chosen subspaces of the original feature space (Ho, 1998) . The outputs of the models are usually combined by majority vote. The Random Subspace algorithm's pseudo codes are shown as followed:
Procedure
In this model, we choose four widely used base classifier for implementing the three ensemble methods: SVM, NB and DT. SVM algorithm has been used for a variety of application and it performs structural risk minimization on a nested set structure of separating hyperplanes (Cortes and Vapnik, 1995) . Navie Bayesian algorithm is a simple classification based on the Bayes theory for conditional probability. Decision Tree algorithm is an easily understandable and transparent sequential model but it has relatively low prediction accuracy compared to other methods. In this study, we chose the widely used method C4.5. Here we use the toolkit WEKA, which includes a collection of machine learning algorithms for solving data mining problems (Hall et al., 2009 ). The AdaBoost, Bagging and Random SubSpace are selected to implement the ensemble algorithms. The drug-pathway associations we used include 643 positive samples and 17390 negative samples, and the positive sample density of the dataset is 0.036.
In order to evaluate the performances of different models, 10-fold cross validation tests are executed on the models. For the datasets, all of the drugpathway samples are randomly spilt into ten subsets with equal size, and nine subsets are combined as the training set and the remaining one subset is taken as the testing set each time. The overview procedure of the model is shown in the Fig.1 . 
RESULTS
Performance Evaluation
Here several metrics, i.e., precision, recall, accuracy (ACC), area under ROC curve (AUC) and the area under the precision-recall curve (AUPR), F-measure (F), are used to evaluate the performances of the models. Among the metrics, accuracy represents the overall accuracy of the classification, precision represents the measure of the reliability of positive instances prediction and recall represents the probability of correct prediction. F-measure is a score from 0 to 1 as a measure of test accuracy. The metrics were calculated in a 10-fold cross-validation procedure by using the equations as followed:
where TP, FP, TN and FN represent the number of true positive, false positive, true negative and false negative samples, respectively.
Performance of Features Integration
To quantitatively assess the efficiency of all the features and each single feature in predicting the drug-pathway interactions, we performed a 10-fold cross validation with the AdaBoost algorithm based on DT classifier, respectively. As a result, the model that integrated features exhibits a better performance than those with single feature (See in Fig. 2) . Further, the Relief method is performed to avoid the redundancy of feature variables. In our study, we get 551 features with positive weight from 764 features after feature selection. By comparison, the selected features have better classification performances than the original features (See in Fig.3 ).
Performance of Ensemble Methods
In this model, we compared the performance of 12 methods, including SVM, NB and DT, and their corresponding ensemble methods of AdaBoost, Bagging and Random Subspace. The performance of base classifiers and ensemble methods based on three base classifiers is shown in Table 2 . As demonstrated in Table 2 , we find all the three base classifiers have a poorer performance than the ensemble methods, and AdaBoost method has the best performance in every base classifier. The possible reason for this situation is that AdaBoost more fully account the weight of each classifier relative to other algorithms.
Next, we compared the three base classifiers in the case of AdaBoost ensemble models. The ROC and PR curves of the three approaches are shown in the Fig. 4 , we can see that the AdaBoost ensemble algorithm based on the DT classifier can achieve the best performance.
New Predictions
Here we used the Comparative Toxicogenomics Database (CTD) (Davis et al., 2015) as reference to validate the predicted interactions. The CTD database integrates chemical, gene, disease and their interactions from curated literatures. There are 502 new predicted interactions and 241 associations have been proved existence by searching the CTD database. For instance, the interaction between the drug 'Theophylline' and the pathway 'Neuroactive ligand-receptor interaction' can be found in both KEGG database and CTD database. Some predicted samples that have been confirmed in CTD database are listed in Table 3 .
In addition, we focused on the pathway: Kegg05223 and associated predicted drugs. We found there are 15 predicted drugs related with the pathway 'Non-small cell lung cancer'. Meanwhile, we confirmed that eleven drugs have associations with the pathway in CTD database. Among the other four drugs, we cannot find the interactions between the drug and the pathway 'Non-small cell lung cancer', but from the aspect of disease we find that the three drug 'Aminoglutethimide', 'Sunitinib malate' and 'sunitinib' have been tested in clinical trials for lung cancer in the literatures (Xiao et al., 2010; Chen et al., 2011; Shin et al., 2013; Xue et al., 2014) , which have been laterally validated that the drugs have associations with this pathway. 
CONCLUSIONS
In this article, we evaluated the ensemble algorithms: AdaBoost, Bagging and Random SubSpace, for predicting drug-pathway interactions based on three base classifiers: SVM, NB and DT. Our results show that ensemble methods have the advantage over the individual classifier on drugpathway interactions prediction. The merit of this study lied in selecting the effective features obtained from drug chemical structure information, drug mode of actions and pathway-related gene information. Some validated results to some extent demonstrated the reliability of the models. Although our method has utilized different types of drug-based and pathway-based information, more useful drug-pathway information can be further mined. Therefore, our future study will focus on fusing more biological prior information to improve the prediction reliability.
